Marlene Pasquet
Overview
Explore the profile of Marlene Pasquet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calvo C, Mornet C, Storey C, Halfon-Domenech C, Pochon C, Tabone M, et al.
Bone Marrow Transplant
. 2025 Mar;
PMID: 40033132
No abstract available.
2.
Largeaud L, Fregona V, Jamrog L, Hamelle C, Dufrechou S, Prade N, et al.
Blood Cancer J
. 2025 Jan;
15(1):7.
PMID: 39885120
GATA2 germline mutations lead to a syndrome characterized by immunodeficiency, vascular disorders and myeloid malignancies. To elucidate how these mutations affect hematopoietic homeostasis, we created a knock-in mouse model expressing...
3.
Brakta C, Tabet A, Puel M, Pacault M, Stolzenberg M, Goudet C, et al.
J Clin Immunol
. 2024 Nov;
45(1):46.
PMID: 39578275
Purpose: CTLA4 deficiency is an inborn error of immunity (IEI) due to heterozygosity for germline loss-of-function variants of the CTLA4 gene located on chromosome 2q33.2. CTLA4 deficiency underlies pleiotropic immune...
4.
Domenech C, Kicinski M, De Moerloose B, Piette C, Chahla W, Kornreich L, et al.
Hemasphere
. 2024 Nov;
8(11):e70025.
PMID: 39540141
Here, we report the results of the prospective cohort study EORTC-CLG 58081 and compare them to the control arm of the randomized phase 3 trial EORTC-CLG 58951, on which treatment...
5.
Thalhammer J, Jeziorski E, Marec-Berard P, Barkaoui M, Barkaoui M, Pagnier A, et al.
Blood
. 2024 Nov;
145(10):1061-1073.
PMID: 39486044
Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglobin <10 g/dL, platelets <100 ×...
6.
Bohlen J, Bagaric I, Vatovec T, Ogishi M, Ahmed S, Cederholm A, et al.
J Clin Invest
. 2024 Oct;
134(20).
PMID: 39403923
Patients heterozygous for germline CBL loss-of-function (LOF) variants can develop myeloid malignancy, autoinflammation, or both, if some or all of their leukocytes become homozygous for these variants through somatic loss...
7.
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poire X, Forcade E, et al.
Br J Haematol
. 2024 Aug;
PMID: 39159950
Modalities and timing of haematopoietic stem cell transplant (HSCT) in patients with GATA2 deficiency are still subject to debate. On June 2022, 67 patients (median age 20.6 years) underwent a...
8.
Dourthe M, Auperin A, Rigaud C, Barbati M, Bonneau J, Buchbinder N, et al.
Haematologica
. 2024 Jul;
109(11):3790-3794.
PMID: 38988265
No abstract available.
9.
Pincez T, Fernandes H, Fahd M, Pasquet M, Abou Chahla W, Granel J, et al.
Am J Hematol
. 2024 Apr;
99(7):1269-1280.
PMID: 38651646
Refractory chronic immune thrombocytopenia (r-cITP) is one of the most challenging situations in chronic immune thrombocytopenia (cITP). Pediatric r-cITP is inconsistently defined in literature, contributing to the scarcity of data....
10.
Houdouin V, Dubus J, Guilmin Crepon S, Rialland F, Bruno B, Jubert C, et al.
Bone Marrow Transplant
. 2024 Mar;
59(6):858-866.
PMID: 38454132
The primary objective of our multicenter prospective study was to describe the incidence of late-onset non-infectious pulmonary complications (LONIPCs) in children undergoing hematopoietic cell transplantation (HCT) using sensitive criteria for...